Shefali Parikh

1.1k total citations
20 papers, 277 citations indexed

About

Shefali Parikh is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Shefali Parikh has authored 20 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Oncology. Recurrent topics in Shefali Parikh's work include Childhood Cancer Survivors' Quality of Life (5 papers), Palliative Care and End-of-Life Issues (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Shefali Parikh is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (5 papers), Palliative Care and End-of-Life Issues (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Shefali Parikh collaborates with scholars based in United States, United Kingdom and India. Shefali Parikh's co-authors include Monica Bessler, Jennifer K. Walter, Chris Feudtner, Douglas L. Hill, Julia E. Szymczak, Dennis Slate, Charles E. Rupprecht, Theodore E. Schall, Michele T. Jay and Stephanie A. Shwiff and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Shefali Parikh

18 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shefali Parikh United States 9 95 74 65 56 35 20 277
Teddy Mselle Tanzania 8 69 0.7× 30 0.4× 31 0.5× 19 0.3× 20 0.6× 17 456
M. L. Kulkarni India 11 46 0.5× 71 1.0× 100 1.5× 63 1.1× 139 4.0× 31 442
J. Leuvenink Netherlands 6 34 0.4× 29 0.4× 26 0.4× 12 0.2× 43 1.2× 6 277
James A. Macer United States 8 88 0.9× 60 0.8× 117 1.8× 7 0.1× 69 2.0× 9 382
Polina Giannelou Greece 16 368 3.9× 102 1.4× 193 3.0× 47 0.8× 29 0.8× 37 673
E.J. Popek United States 10 58 0.6× 46 0.6× 66 1.0× 95 1.7× 14 0.4× 12 351
P. J. van Dijken Netherlands 9 28 0.3× 33 0.4× 48 0.7× 34 0.6× 9 0.3× 13 283
Sarah Borwein United States 6 68 0.7× 43 0.6× 27 0.4× 24 0.4× 16 0.5× 8 223
Ganesh Mohan India 10 28 0.3× 24 0.3× 12 0.2× 28 0.5× 78 2.2× 50 264
Anke de Groot Netherlands 7 153 1.6× 26 0.4× 167 2.6× 6 0.1× 26 0.7× 11 335

Countries citing papers authored by Shefali Parikh

Since Specialization
Citations

This map shows the geographic impact of Shefali Parikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shefali Parikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shefali Parikh more than expected).

Fields of papers citing papers by Shefali Parikh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shefali Parikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shefali Parikh. The network helps show where Shefali Parikh may publish in the future.

Co-authorship network of co-authors of Shefali Parikh

This figure shows the co-authorship network connecting the top 25 collaborators of Shefali Parikh. A scholar is included among the top collaborators of Shefali Parikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shefali Parikh. Shefali Parikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olsson‐Brown, Anna, Mark Baxter, Laura Feeney, et al.. (2022). The association of pre-existing autoimmune disease and immune-related adverse events secondary to immune checkpoint inhibition therapy in a UK multicenter cohort.. Journal of Clinical Oncology. 40(16_suppl). 2522–2522.
2.
Parikh, Shefali, et al.. (2021). Live streaming ward rounds using wearable technology to teach medical students: a pilot study. BMJ Simulation & Technology Enhanced Learning. 7(6). 494–500. 16 indexed citations
3.
Olsson‐Brown, Anna, Mark Baxter, Caroline Dobeson, et al.. (2021). Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.. Journal of Clinical Oncology. 39(15_suppl). 12026–12026. 5 indexed citations
4.
Walter, Jennifer K., Douglas L. Hill, Theodore E. Schall, et al.. (2021). An Interprofessional Team-Based Intervention to Address Barriers to Initiating Palliative Care in Pediatric Oncology: A Multiple-Method Evaluation of Feasibility, Acceptability, and Impact. Journal of Pain and Symptom Management. 62(6). 1135–1144. 6 indexed citations
5.
Parikh, Shefali, Pooja Jain, K. Clarke, et al.. (2020). 1378P Is 30-day mortality after systemic anticancer therapy in lung cancer in the era of varied treatments still relevant?. Annals of Oncology. 31. S878–S878. 2 indexed citations
6.
Olsson‐Brown, Anna, Mark Baxter, Caroline Dobeson, et al.. (2020). Real-world outcomes of immune-related adverse events in 2,125 patients managed with immunotherapy: A United Kingdom multicenter series.. Journal of Clinical Oncology. 38(15_suppl). 7065–7065. 6 indexed citations
7.
Hill, Douglas L., et al.. (2019). Seven Types of Uncertainty When Clinicians Care for Pediatric Patients With Advanced Cancer. Journal of Pain and Symptom Management. 59(1). 86–94. 19 indexed citations
8.
Meyers, Melissa R., et al.. (2019). “It Can’t Be the Dialysis that Kills the Child…” Partnering Pediatric Palliative Care with Care for Children with End-Stage Renal Disease (TH366). Journal of Pain and Symptom Management. 57(2). 392–392. 1 indexed citations
9.
10.
11.
Szymczak, Julia E., Theodore E. Schall, Douglas L. Hill, et al.. (2018). Pediatric Oncology Providers' Perceptions of a Palliative Care Service: The Influence of Emotional Esteem and Emotional Labor. Journal of Pain and Symptom Management. 55(5). 1260–1268. 35 indexed citations
12.
Parikh, Shefali, et al.. (2017). Early Aspirin administration post Coronary Artery Bypass Graft Surgery – Changing hospital culture through a two-cycled audit. BMJ Quality Improvement Reports. 6(1). u211402.w6306–u211402.w6306. 1 indexed citations
13.
14.
Muranjan, Mamta, Sunil Karande, Shefali Parikh, & Shilpa Sankhe. (2014). A mistaken identity: rhabdomyosarcoma of the middle ear cleft misdiagnosed as chronic suppurative otitis media with temporal lobe abscess. BMJ Case Reports. 2014. bcr2014206615–bcr2014206615. 5 indexed citations
15.
Garçon, Loïc, Jingping Ge, Jason A. Mills, et al.. (2013). Ribosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients. Blood. 122(6). 912–921. 64 indexed citations
16.
Shah, Ira & Shefali Parikh. (2012). HIV Genotype Resistance Testing in Antiretroviral (ART) Exposed Indian Children—A Need of the Hour. The Indian Journal of Pediatrics. 80(4). 340–342. 1 indexed citations
17.
Parikh, Shefali & Monica Bessler. (2012). Recent insights into inherited bone marrow failure syndromes. Current Opinion in Pediatrics. 24(1). 23–32. 31 indexed citations
18.
Shwiff, Stephanie A., Ray T. Sterner, Michele T. Jay, et al.. (2007). DIRECT AND INDIRECT COSTS OF RABIES EXPOSURE: A RETROSPECTIVE STUDY IN SOUTHERN CALIFORNIA (1998–2002). Journal of Wildlife Diseases. 43(2). 251–257. 48 indexed citations
19.
Pant, M. C., et al.. (2005). Role of immuno-therapy as a adjuvant treatment in advance head & neck cancer, patient receiving chemo radiotherapy. Journal of Clinical Oncology. 23(16_suppl). 2598–2598. 3 indexed citations
20.
Sampath, Gadey, et al.. (2004). Rabies post-exposure prophylaxis in malnourished children exposed to suspect rabid animals. Vaccine. 23(9). 1102–1105. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teddy Mselle Breakdown of academic impact, for papers by M. L. Kulkarni Breakdown of academic impact, for papers by J. Leuvenink Breakdown of academic impact, for papers by James A. Macer Breakdown of academic impact, for papers by Polina Giannelou Breakdown of academic impact, for papers by E.J. Popek Breakdown of academic impact, for papers by P. J. van Dijken Breakdown of academic impact, for papers by Sarah Borwein Breakdown of academic impact, for papers by Ganesh Mohan Breakdown of academic impact, for papers by Anke de Groot
Rankless by CCL
2026